This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Lankenau Institute for Medical Research. Active years: 2011-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2023
Title: The Innovative Mind of Richard Metz: Advancements in Medical Research
Introduction
Richard Metz, an accomplished inventor based in Pennington, NJ, has made significant contributions to the field of medical research. With a total of three patents to his name, his work primarily focuses on the intricate mechanisms of indoleamine 2,3-dioxygenase-2 (IDO2), a vital enzyme in the regulation of immune responses.
Latest Patents
Among Richard's groundbreaking inventions are two latest patents related to IDO2. The first patent details the nucleic acid molecules encoding IDO2, which include the nucleotide and amino acid sequences of this critical enzyme, as well as the methods of use associated with these sequences. The second patent also revolves around IDO2, specifically concerning antibodies that target this enzyme, again highlighting the nucleotide and amino acid sequences and relevant usage methodologies. These innovations hold the potential for advancing therapeutic approaches in immune regulation.
Career Highlights
Richard Metz has established himself as a key figure in medical research, particularly through his position at the Lankenau Institute for Medical Research. His expertise in molecular biology and immunology has enabled him to explore the roles of various enzymes and their implications for human health.
Collaborations
Collaboration is a hallmark of Richard’s career. One of his notable collaborators is George C. Prendergast, a fellow researcher at the Lankenau Institute. Together, they have delved into the complexities of immune response regulation and have made significant strides in understanding how IDO2 can be manipulated for therapeutic benefits.
Conclusion
Richard Metz exemplifies the spirit of innovation within the medical research community. His patents not only reflect his dedication to scientific advancement but also pave the way for future inquiries into the therapeutic potential of enzymes like IDO2. As he continues his work at the Lankenau Institute for Medical Research, the future of his contributions looks promising and is sure to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile